SUNPHARMA's weekly performance was disappointing, with a return of -3.52% and a Sharpe Ratio of -0.80, indicating poor risk-adjusted returns. The stock's volatility was high at 23.53%, and it experienced a max drawdown of -3.52%. Compared to its peers, SUNPHARMA underperformed, with DRREDDY, DIVISLAB, and HINDUNILVR all posting positive returns. Overall, SUNPHARMA was a high-risk stock this week.

[Volatility: 23.53%]